Atlas Trials

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT03308682 · UNKNOWN

Trial details

NCT number
NCT03308682
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2017-04-30
Primary completion
2018-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.